Companies / Bionano Genomics, Inc.

Bionano Genomics, Inc.

Nasdaq: BNGOCIK 1411690SAN DIEGO, CA

Financials · FY2025

Revenue$28.51M
Net income$-26.39M
Total debt$0
Cash$3.73M
Diluted EPS$-4.85
Shares outstanding11.8M

Ownership

11.8M shares outstanding · as of Aug 6, 2026
0.03%Insiders
Ownership
Insiders0.03%3,719
Institutions8.84%1,041,220
Public float91.13%10,732,061

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Holmlin R. ErikCEOPRESIDENT AND CEO · Director
0.01%1,657
Oldakowski MarkCHIEF OPERATING OFFICER
<0.01%895
Chaubey AlkaCHIEF MEDICAL OFFICER
<0.01%644
Dixon Jonathan V.GENERAL COUNSEL
<0.01%263
Adamchak MarkPrincipal Accounting Officer
<0.01%260
Barker David LDirector
——
Twomey Christopher JDirector
——

Institutional holders 33

View all →
HolderValue% of shares
DRW Securities, LLC$257.7K1.43%
Geode Capital Management, LLC$196.0K1.42%
Vanguard Group Inc$125.9K0.70%
Carret Asset Management, LLC$67.5K0.37%
Two Sigma Investments, LP$62.0K0.34%
Renaissance Technologies LLC$57.0K0.41%
Jane Street Group, LLC$33.9K0.19%
Prudential Financial Inc$32.8K0.24%
Northern Trust Corp$31.4K0.17%
R Squared Ltd$21.1K0.12%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 17, 2026Holmlin R. Erik
CEO
OtherCommon Stock$56-51
-2.99%
1,657
0.01% of shares
low
Feb 17, 2026Oldakowski Mark
Executive
OtherCommon Stock$22-20
-2.19%
895
<0.01% of shares
low
Feb 17, 2026Chaubey Alka
Executive
OtherCommon Stock$20-18
-2.72%
644
<0.01% of shares
low
Feb 17, 2026Dixon Jonathan V.
Executive
OtherCommon Stock$7-6
-2.23%
263
<0.01% of shares
low
Feb 17, 2026Adamchak Mark
Executive
OtherCommon Stock$3-3
-1.14%
260
<0.01% of shares
low
May 14, 2026Twomey Christopher J
Director
GrantStock Option (Right to Buy)—+9K
9,149
0.08% of shares
low
May 14, 2026Barker David L
Director
GrantStock Option (Right to Buy)—+9K
9,149
0.08% of shares
low
Feb 2, 2026Chaubey Alka
Executive
GrantStock Option (Right to Buy)—+28K
27,737
0.24% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Lind Global Fund III LPPassive13G/A———
CVI Investments, Inc.Passive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BNGOCommon StockEquity09075F404BBG001KWWRS9